Control Bionics (ASX:CBL) OCF Margin %: -80.54% (As of Dec. 2025)


What is Control Bionics OCF Margin %?

Control Bionics ASX:CBL -2.30% OCF Margin % is -80.54% as of Dec. 2025. The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Control Bionics ranks worse than 82.21% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Control Bionics's Cash Flow from Operations for the six months ended in Dec. 2025 was A$-2.22 Mil. Control Bionics's Revenue for the six months ended in Dec. 2025 was A$2.76 Mil. Therefore, Control Bionics's OCF Margin % for the quarter that ended in Dec. 2025 was -80.54%.

As of today, Control Bionics's current OCF Yield % is -11.01%.

The historical rank and industry rank for Control Bionics's OCF Margin % or its related term are showing as below:

ASX:CBL' s OCF Margin % Range Over the Past 10 Years
Min: -157.24   Med: -95.81   Max: -71.47
Current: -69.3

During the past 6 years, the highest OCF Margin % of Control Bionics was -71.47%. The lowest was -157.24%. And the median was -95.81%.

ASX:CBL's OCF Margin % is ranked worse than
82.21% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs ASX:CBL: -69.30

Control Bionics OCF Margin % Related Terms

Control Bionics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Control Bionics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics OCF Margin % Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Margin %
Get a 7-Day Free Trial -101.58 -157.24 -83.29 -95.81 -71.47

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.83 -140.54 -85.13 -59.59 -80.54

ASX:CBL vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, Control Bionics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Control Bionics OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Control Bionics's OCF Margin % falls into.


Control Bionics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Control Bionics's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-4.269/5.973
=-71.47 %

Control Bionics's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.223/2.76
=-80.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -80.54% mean?
Control Bionics (ASX:CBL) has a OCF Margin % of -80.54% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Control Bionics and its competitors. According to the industry distribution chart, Control Bionics ranks #670 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 82.2%.
Is Control Bionics' OCF Margin % too high?
Control Bionics' current OCF Margin % is -80.54%. Based on the distribution chart, Control Bionics ranks #670 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Control Bionics' OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Control Bionics ranks #670 out of 815 companies for OCF Margin %. This places Control Bionics in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Control Bionics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Control Bionics's current OCF Margin % is -80.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.09 — trading 183.3% above its estimated fair value. The current OCF Margin % is -80.54%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current OCF Margin % is -80.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.